Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
The latest quarterly goodwill is $48.48 Billion with a quarter-over-quarter change of -0.16%. Goodwill is an intangible asset recorded when a company acquires another business for more than the fair value of its identifiable net assets.
Reported quarterly goodwill; no daily interpolation.
$48.48B
$48.48 Billion
-0.16%
vs. $48.56B prior quarter
96
Quarters of data available
| Period | Goodwill | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $48.48B | −$79.00M | -0.16% |
| Quarter ended Mar 2026 | $48.56B | −$214.00M | -0.44% |
| Quarter ended Dec 2025 | $48.77B | +$724.00M | +1.51% |
| Quarter ended Sep 2025 | $48.05B | −$69.00M | -0.14% |
| Quarter ended Jun 2025 | $48.12B | +$3.65B | +8.21% |
| Quarter ended Mar 2025 | $44.47B | +$268.00M | +0.61% |
| Quarter ended Dec 2024 | $44.20B | −$599.00M | -1.34% |
| Quarter ended Sep 2024 | $44.80B | +$549.00M | +1.24% |
| Quarter ended Jun 2024 | $44.25B | +$7.63B | +20.85% |
| Quarter ended Mar 2024 | $36.62B | +$58.00M | +0.16% |
| Quarter ended Dec 2023 | $36.56B | +$434.00M | +1.20% |
| Quarter ended Oct 2023 | $36.12B | −$9.32B | -20.50% |
| Quarter ended Jul 2023 | $45.44B | −$135.00M | -0.30% |
| Quarter ended Apr 2023 | $45.58B | +$9.53B | +26.43% |
| Quarter ended Dec 2022 | $36.05B | +$2.66B | +7.98% |
| Quarter ended Oct 2022 | $33.38B | −$783.00M | -2.29% |
| Quarter ended Jul 2022 | $34.17B | −$769.00M | -2.20% |
| Quarter ended Apr 2022 | $34.94B | −$311.00M | -0.88% |
| Quarter ended Dec 2021 | $35.25B | −$323.00M | -0.91% |
| Quarter ended Oct 2021 | $35.57B | −$250.00M | -0.70% |
| Quarter ended Jul 2021 | $35.82B | +$131.00M | +0.37% |
| Quarter ended Apr 2021 | $35.69B | −$705.00M | -1.94% |
| Quarter ended Dec 2020 | $36.39B | +$2.09B | +6.08% |
| Quarter ended Sep 2020 | $34.31B | +$417.00M | +1.23% |
| Quarter ended Jun 2020 | $33.89B | +$419.00M | +1.25% |
| Quarter ended Mar 2020 | $33.47B | −$168.00M | -0.50% |
| Quarter ended Dec 2019 | $33.64B | +$348.00M | +1.05% |
| Quarter ended Sep 2019 | $33.29B | −$370.00M | -1.10% |
| Quarter ended Jun 2019 | $33.66B | +$2.21B | +7.03% |
| Quarter ended Mar 2019 | $31.45B | +$997.00M | +3.27% |
| Quarter ended Dec 2018 | $30.45B | −$249.00M | -0.81% |
| Quarter ended Sep 2018 | $30.70B | +$356.00M | +1.17% |
| Quarter ended Jul 2018 | $30.35B | −$803.00M | -2.58% |
| Quarter ended Apr 2018 | $31.15B | −$757.00M | -2.37% |
| Quarter ended Dec 2017 | $31.91B | +$598.00M | +1.91% |
| Quarter ended Oct 2017 | $31.31B | +$74.00M | +0.24% |
| Quarter ended Jul 2017 | $31.23B | +$6.39B | +25.72% |
| Quarter ended Apr 2017 | $24.84B | +$2.04B | +8.94% |
| Quarter ended Dec 2016 | $22.80B | −$366.00M | -1.58% |
| Quarter ended Oct 2016 | $23.17B | +$1.07B | +4.83% |
| Quarter ended Jul 2016 | $22.10B | +$256.00M | +1.17% |
| Quarter ended Apr 2016 | $21.85B | +$219.00M | +1.01% |
| Quarter ended Dec 2015 | $21.63B | +$350.00M | +1.64% |
| Quarter ended Sep 2015 | $21.28B | −$214.00M | -1.00% |
| Quarter ended Jun 2015 | $21.49B | +$148.00M | +0.69% |
| Quarter ended Mar 2015 | $21.34B | −$487.00M | -2.23% |
| Quarter ended Dec 2014 | $21.83B | +$196.00M | +0.91% |
| Quarter ended Sep 2014 | $21.64B | −$353.00M | -1.61% |
| Quarter ended Jun 2014 | $21.99B | −$189.00M | -0.85% |
| Quarter ended Mar 2014 | $22.18B | −$620.00M | -2.72% |
| Quarter ended Dec 2013 | $22.80B | −$54.00M | -0.24% |
| Quarter ended Sep 2013 | $22.85B | +$515.00M | +2.31% |
| Quarter ended Jun 2013 | $22.34B | −$12.00M | -0.05% |
| Quarter ended Mar 2013 | $22.35B | −$75.00M | -0.33% |
| Quarter ended Dec 2012 | $22.42B | +$647.00M | +2.97% |
| Quarter ended Sep 2012 | $21.78B | +$365.00M | +1.70% |
| Quarter ended Jul 2012 | $21.41B | +$5.07B | +31.05% |
| Quarter ended Apr 2012 | $16.34B | +$201.00M | +1.25% |
| Quarter ended Dec 2011 | $16.14B | +$89.00M | +0.55% |
| Quarter ended Oct 2011 | $16.05B | −$194.00M | -1.19% |
| Quarter ended Jul 2011 | $16.24B | +$117.00M | +0.73% |
| Quarter ended Apr 2011 | $16.13B | +$832.00M | +5.44% |
| Quarter ended Dec 2010 | $15.29B | −$81.00M | -0.53% |
| Quarter ended Oct 2010 | $15.38B | +$747.00M | +5.11% |
| Quarter ended Jul 2010 | $14.63B | −$349.00M | -2.33% |
| Quarter ended Apr 2010 | $14.98B | +$115.00M | +0.77% |
| Quarter ended Dec 2009 | $14.86B | −$155.00M | -1.03% |
| Quarter ended Sep 2009 | $15.02B | +$865.00M | +6.11% |
| Quarter ended Jun 2009 | $14.15B | +$69.00M | +0.49% |
| Quarter ended Mar 2009 | $14.08B | +$364.00M | +2.65% |
| Quarter ended Dec 2008 | $13.72B | −$556.00M | -3.89% |
| Quarter ended Sep 2008 | $14.28B | −$251.00M | -1.73% |
| Quarter ended Jun 2008 | $14.53B | −$89.00M | -0.61% |
| Quarter ended Mar 2008 | $14.62B | +$492.00M | +3.48% |
| Quarter ended Dec 2007 | $14.12B | +$83.00M | +0.59% |
| Quarter ended Sep 2007 | $14.04B | +$286.00M | +2.08% |
| Quarter ended Jul 2007 | $13.75B | +$91.00M | +0.67% |
| Quarter ended Apr 2007 | $13.66B | +$323.00M | +2.42% |
| Quarter ended Dec 2006 | $13.34B | +$6.57B | +97.07% |
| Quarter ended Oct 2006 | $6.77B | +$112.00M | +1.68% |
| Quarter ended Jul 2006 | $6.66B | +$197.00M | +3.05% |
| Quarter ended Apr 2006 | $6.46B | +$470.00M | +7.85% |
| Quarter ended Dec 2005 | $5.99B | +$5.99B | N/A |
| Quarter ended Oct 2005 | $0 | +$0 | N/A |
| Quarter ended Jul 2005 | $0 | +$0 | N/A |
| Quarter ended Apr 2005 | $0 | +$0 | N/A |
| Quarter ended Dec 2004 | $0 | +$0 | N/A |
| Quarter ended Sep 2004 | $0 | +$0 | N/A |
| Quarter ended Jun 2004 | $0 | +$0 | N/A |
| Quarter ended Mar 2004 | $0 | +$0 | N/A |
| Quarter ended Dec 2003 | $0 | +$0 | N/A |
| Quarter ended Sep 2003 | $0 | +$0 | N/A |
| Quarter ended Jun 2003 | $0 | +$0 | N/A |
| Quarter ended Mar 2003 | $0 | +$0 | N/A |
| Quarter ended Dec 2002 | $0 | +$0 | N/A |
| Quarter ended Sep 2002 | $0 | N/A | N/A |